Death receptor 5 expression is inversely correlated with prostate cancer progression. - Wikidata - awgldk - TriplyDB

Death receptor 5 expression is inversely correlated with prostate cancer progression.

Death receptor 5 expression is inversely correlated with prostate cancer progression.

http://www.wikidata.org/entity/Q34426868

about

Diminished expression of CRHR2 in human colon cancer promotes tumor growth and EMT via persistent IL-6/Stat3 signaling CRHR2/Ucn2 signaling is a novel regulator of miR-7/YY1/Fas circuitry contributing to reversal of colorectal cancer cell resistance to Fas-mediated apoptosis.RKIP: A Key Regulator in Tumor Metastasis Initiation and Resistance to Apoptosis: Therapeutic Targeting and Impact

P2860

Q36174823-74FBA948-21DA-4247-ABD7-5376E8BFF7BE Q47773932-F0180334-726D-4070-93A5-453F6072D68C Q58704356-489651BD-600F-4658-B0A1-4C38FDA93B0D

P2860

Death receptor 5 expression is inversely correlated with prostate cancer progression.

http://www.wikidata.org/entity/Q34426868

description

2014 nî lūn-bûn

@nan

2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Death receptor 5 expression is inversely correlated with prostate cancer progression.

@ast

Death receptor 5 expression is inversely correlated with prostate cancer progression.

@en

Death receptor 5 expression is inversely correlated with prostate cancer progression.

@nl

type

label

Death receptor 5 expression is inversely correlated with prostate cancer progression.

@ast

Death receptor 5 expression is inversely correlated with prostate cancer progression.

@en

Death receptor 5 expression is inversely correlated with prostate cancer progression.

@nl

prefLabel

Death receptor 5 expression is inversely correlated with prostate cancer progression.

@ast

Death receptor 5 expression is inversely correlated with prostate cancer progression.

@en

Death receptor 5 expression is inversely correlated with prostate cancer progression.

@nl

P1433

Q34426868-D8B46852-837B-4254-A7EF-9ACC8DD6EEFC

P1476

Q34426868-F1DD8184-2CFD-4992-9F8F-4D0D645C8902

P2093

Q34426868-101A2D69-ED5D-4228-9E44-1163C705FA98

Q34426868-208DB720-0461-40B5-AEAB-6A231FE186CB

Q34426868-4144677F-A2B8-4BD7-B962-E87B81E51AA7

Q34426868-4DDDE83A-F2E6-4DE9-9E9E-C2DB91EA8A17

Q34426868-5D7DC23B-0C06-4079-86F2-799319DF2D4C

Q34426868-6364042F-6AAE-46E2-ACFC-B6FAD1283FB4

Q34426868-E13EFE41-511B-41C9-9F05-C103BFF17EEB

Q34426868-F14748D4-F044-480E-AFE2-66F517E77740

Q34426868-F5DF69D5-AC11-4734-B879-562AABFCB291

P2860

Q34426868-05D91E06-628B-4FB1-8016-AA8F4D371F9D

Q34426868-09E358B3-765D-49BF-BA96-F6BBA8FA8583

Q34426868-11DEC4AE-A8F7-4A4A-B258-80EE57BAB104

Q34426868-13EBE930-54E3-48AA-9C0D-DFDB1C3AB9B1

Q34426868-1454E92D-8168-4A07-A979-91CC98C8565A

Q34426868-1A93980B-8DB5-4436-BCAA-CC264CBC42E0

Q34426868-24156DA1-48F4-4B9D-A40B-CC5225066736

Q34426868-24F62DB9-6E18-4494-BE36-B5BD7F6DF22B

Q34426868-2619ED8A-0B2A-42DB-BBA5-18561B5DE10A

Q34426868-2B188396-DE5C-4DC9-97EE-EC41F2E766D5

P304

Q34426868-9A4268B5-A0C9-4209-B83E-CD524DFA1130

P31

Q34426868-634B79DF-4DB1-4FDB-9692-AB0D8D0B2457

P356

Q34426868-1823C955-C214-46EA-9A3F-B535F7B3B8C5

P433

Q34426868-2E250368-96E1-481A-B08C-4AD1E4C7ACF2

P478

Q34426868-6442C463-3F31-40B4-AC7B-6BAF1AECB57F

P50

Q34426868-ACDED0AB-D579-4892-B8DF-1C4209FF7928

Q34426868-B3B5251D-42BD-4AD3-81B8-37016946DA11

P577

Q34426868-61312DC8-D935-4CCB-829A-42EC90042A98

P5875

Q34426868-8535AD97-EA0B-40A7-A43F-44B32369D85A

P698

Q34426868-88AFFDF0-C582-44D5-8E82-A081387FD5D7

P932

Q34426868-76C99C51-2157-4A53-86BB-E32455B33F36

P356

P1433

Molecular Medicine Reports

P1476

Death receptor 5 expression is inversely correlated with prostate cancer progression.

@en

P2093

Ana Lilia Sandoval-Mejia

http://www.w3.org/2001/XMLSchema#string

Angeles Hernandez-Cueto

http://www.w3.org/2001/XMLSchema#string

Benjamin Bonavida

http://www.w3.org/2001/XMLSchema#string

Carlos Jimenez-Gutierrez

http://www.w3.org/2001/XMLSchema#string

Daniel Hernandez-Cueto

http://www.w3.org/2001/XMLSchema#string

Gabriela Antonio-Andres

http://www.w3.org/2001/XMLSchema#string

Marisela Mendoza-Marin

http://www.w3.org/2001/XMLSchema#string

Rosario Mora-Campos

http://www.w3.org/2001/XMLSchema#string

Sara Huerta-Yepez

http://www.w3.org/2001/XMLSchema#string

P2860

Risk assessment for prostate cancer metastasis and mortality at the time of diagnosis

Cancer statistics, 2012

IG20 (MADD splice variant-5), a proapoptotic protein, interacts with DR4/DR5 and enhances TRAIL-induced apoptosis by increasing recruitment of FADD and caspase-8 to the DISC

Apoptosis: a review of programmed cell death

Socioeconomic status, healthcare density, and risk of prostate cancer among African American and Caucasian men in a large prospective study

Identification and validation of commonly overexpressed genes in solid tumors by comparison of microarray data.

Analysis of death receptor 5 and caspase-8 expression in primary and metastatic head and neck squamous cell carcinoma and their prognostic impact

A neural network predicts progression for men with gleason score 3+4 versus 4+3 tumors after radical prostatectomy.

Gossypol induces death receptor-5 through activation of the ROS-ERK-CHOP pathway and sensitizes colon cancer cells to TRAIL

Direct binding of Fas-associated death domain (FADD) to the tumor necrosis factor-related apoptosis-inducing ligand receptor DR5 is regulated by the death effector domain of FADD.

P304

2279-2286

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/MMR.2014.2504

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-08-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

265213546

http://www.w3.org/2001/XMLSchema#string

P698

25174820

http://www.w3.org/2001/XMLSchema#string

P932

4214341

http://www.w3.org/2001/XMLSchema#string